A Johns Hopkins Medicine study reports evidence that time-restricted eating (TRE) — a form of intermittent fasting that involves only eating during a consistent, daily 8- to 10-hour… read more.
A new Scientific Statement released today by the Endocrine Society highlights the benefits of obesity treatment beyond weight loss, including improvements in overall health and reducing the risk… read more.
Men already at risk genetically for the most common form of hair loss have a 7 percent added risk of losing their hair if they use drugs like… read more.
GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU’s Pennington… read more.
Researchers have developed a breath detector with a chemical sensor that sniffs out when your body is burning fat through a single exhale. Reporting on July 22 in the Cell Press journal Device, the… read more.
In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers predict that the anticipated price reductions of up to 70% will dramatically… read more.
Does informing people about their genetic risk of obesity help them change their habits and lose excess weight? A study, published in the journal Obesity Reviews by scientists including researchers… read more.
More people are living with severe obesity, and weight-loss medication is being used widely. But what does that mean for overall health beyond weight loss? A new study… read more.
Adolescents with obesity achieve the greatest short-term weight reduction when obesity management medications are used alongside lifestyle treatment, according to a systematic review and network meta-analysis published in… read more.
A target trial emulation estimated the risks associated with glucagon-like peptide-1 receptor agonist (GLP-1RA) exposure in early pregnancy. The findings did not indicate substantially increased risk for nonlive… read more.
People prescribed GLP-1 medications are more likely to start-and-stop than most people assume, according to a study being presented Sunday at ENDO 2026, the Endocrine Society’s annual meeting… read more.
People who work fewer hours each year appear to have a lower risk of obesity, according to an Australian study presented at the European Congress on Obesity in… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
